🔎 Trials Near Me

Home › Abdominal Aortic Aneurysm › NCT04246463

Terumo Aortic Global Endovascular Registry

RecruitingObservational study

A Global Post Market Evaluation of Terumo Aortic Endovascular Grafts

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Minimum age as per local regulations
* Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
* Ability to provide informed consent

  o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR).
* Willingness to comply with the registry protocol
* Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up.

Exclusion Criteria:

Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure.

About the study

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

What is being tested

Sponsor: Vascutek Ltd. · Participants: 1,000 · Started: Dec 17, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT04246463

Locations in the U.S.

CaliforniaLong Beach Memorial Medical Center, Long Beach
ColoradoUniversity of Colorado Anschutz Medical Campus, Aurora
UC Health Memorial Hospital Center, Colorado Springs
ConnecticutYale University, New Haven
District of ColumbiaMedStar Washington Hospital Center, Washington D.C.
FloridaUniversity of Florida, Gainesville
IllinoisLoyola University of Chicago (Loyola), Chicago
IndianaAscension St. Vincent Heart Center, Indianapolis
MichiganUniversity of Michigan, Ann Arbor
New JerseyCooper University Hospital, Camden
PennsylvaniaUniversity of Pennsylvania, Philadelphia
University of Pittsburgh, Pittsburgh
TexasAscension Texas Cardiovascular / UT Dell Medical School, Austin
Baylor, Scott & White Health (BSW Health), Texas City
UtahUniversity of Utah, Salt Lake City
VirginiaUniversity of Virgina, Charlottesville
Sentara Heart Hospital, Norfolk

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.